Neutralization by "antineoplastin" of insulin-activated nitric oxide synthase antibody and its effects in cancers.

MLA

Sinha, Asru K., et al. “Neutralization by ‘Antineoplastin’ of Insulin-Activated Nitric Oxide Synthase Antibody and Its Effects in Cancers.” Journal of Cancer Research and Clinical Oncology, vol. 128, no. 12, Dec. 2002, pp. 659–68. EBSCOhost, https://doi.org/10.1007/s00432-002-0376-8.

APA

Sinha, A. K., Acharya, K., Bhattacharya, S., Patra, S. C., Guha, M., Ray, U., Ray, S. B., Khan, G. A., Chakraborty, K., Biswas, J., & Mazumdar, S. (2002). Neutralization by “antineoplastin” of insulin-activated nitric oxide synthase antibody and its effects in cancers. Journal of Cancer Research and Clinical Oncology, 128(12), 659–668. https://doi.org/10.1007/s00432-002-0376-8

Chicago

Sinha, Asru K, Krishnendu Acharya, Sujoy Bhattacharya, Sharmistha Chakraborty Patra, Manti Guha, Udayan Ray, Shyamali Basu Ray, et al. 2002. “Neutralization by ‘Antineoplastin’ of Insulin-Activated Nitric Oxide Synthase Antibody and Its Effects in Cancers.” Journal of Cancer Research and Clinical Oncology 128 (12): 659–68. doi:10.1007/s00432-002-0376-8.